Losartan fails to slow down progression of more advanced Alzheimer's, Lancet study finds Hina Zahid20 Nov 2021 9:00 AM ISTCommon blood pressure drug Losartan, did not reduce rate of brain atrophy in clinically diagnosed mild-to-moderate Alzheimer's disease, finds a new...
Alzheimer's drug price will be competitive: Roche executive Ruchika Sharma13 Nov 2021 10:00 AM ISTNew Delhi: Roche Holding AG, still months away from seeking regulatory approval of its experimental Alzheimer's drug, is already taking aim at rival...
Baseline MRI atrophy may predict 2-year cognitive outcomes in early-onset Alzheimer's disease: Study Medha Baranwal27 Oct 2021 9:00 AM ISTSpain: A recent study has reported that baseline MRI findings can predict two-year cognitive outcomes in patients with early-onset Alzheimer's disease...
Diuretic Bumetanide may be potential candidate for Alzheimer's treatment Hina Zahid22 Oct 2021 9:00 AM ISTDiuretic bumetanide may be a potential candidate for an Alzheimer's disease treatment for those who are at genetic risk, according to findings...
Antioxidant intake may help prevent Alzheimer's disease, suggests study Hina Zahid15 Oct 2021 11:00 AM ISTOxidative stress is a unifying paradigm of functional and structural brain changes observed in Alzheimer's disease.Researchers team at Mohamed Haddad...
Chronic hyperglycemia in type 2 diabetes linked to alzheimer's disease: Study Medha Baranwal6 Oct 2021 11:22 AM IST Chronic hyperglycemia may alter working memory performance and change aspects of working memory networks. USA: A team of neuroscientists...
Methylphenidate effective treatment of apathy in Alzheimer's Disease, finds JAMA study MD Editorial Team30 Sept 2021 9:15 AM ISTUSA: A recent study in the JAMA Neurology journal has found methylphenidate to be a safe and effective medication for the treatment of apathy in...
Granules India, Jubilant Cadista recall products in US Ruchika Sharma13 Sept 2021 1:23 PM ISTNew Delhi: Generic drug makers Granules India and Jubilant Cadista are recalling different products in the US, the world's largest market for...
Suven Life Sciences announces initiation of phase 3 trial of Alzheimer's drug Medical Dialogues Team22 Aug 2021 10:15 AM ISTHyderabad: Biopharmaceutical company, Suven Life Sciences, has announced the initiation of a phase 3 clinical trial of SUVN-502 (Masupirdine), a 5-HT6...
Widespread pain tied to increased risk of dementia and stroke: Study Hina Zahid17 Aug 2021 9:00 AM ISTThe findings provide convincing evidence that [widespread pain] may be a risk factor for all-cause dementia, [Alzheimer's disease], and stroke.USA:...
AAN issues updated ethical guidelines for dementia diagnosis and care Hina Zahid20 July 2021 11:30 AM ISTUSA: The American Academy of Neurology (AAN) has issued an ethical guideline for dementia diagnosis and care. The guideline, published in the AAN...
GSK, Alector enter USD 2.2 billion deal for Parkinson's, Alzheimer's drugs Ruchika Sharma5 July 2021 11:00 AM ISTUK: GlaxoSmithKline Plc and U.S. firm Alector Inc will together develop antibody-based treatments for Parkinson's, Alzheimer's and other similar...
